One hundred and forty-three HIV-infected pregnant women treated with highly active antiretroviral therapy for prevention of mother-to-child transmission during a five-year period and their offspring were studied retrospectively. Two mothers died during the period of study and no infant was infected. The study revealed a good outcome and compliance for follow-up.